Systemic-Onset Juvenile Idiopathic Arthritis with unusual
Cutaneous Manifestation and peripheral eosinophilia: Case Report
Author details:
Albraa Babiker , MBBS, Omdurman Islamic
University, Faculty of Medicine. (Author)
Anas Babiker and Mohammedalmujtaba Gamar, MBBS, University of Khartoum,
Faculty of Medicine. (Co-Author)
Abstract
Introduction: Systemic-onset juvenile idiopathic arthritis (SoJIA) is
unique subtype of juvenile idiopathic arthritis (JIA) with very special
clinical manifestations, complications and management options. The
simultaneous presentation of tinea capitis has not been reported in the
context of Systemic-Onset Juvenile Idiopathic Arthritis before.The case: in
march 2021 a 5-years old Sudanese male presented to Ahmed Gasim Hospital
with fever and bilateral ankle arthritis in a background of extensive
scalp lesions which were scaly, itchy and associated with hair loss. On
examination: his weight was 15 kg (on the 5thcentile). There was cervical lymphadenopathy, hepatomegaly and swelling
and tenderness in both ankle joints with restriction of movements.
Complete blood counts revealed leucocytosis, thrombocytosis, mild
eosinophilia and microcytic hypochromic anaemia. Anti-dsDNA antibody was
45 IU/ml (positive), ANA profile was 0,8 Ratio (Equivocal), CRP was 34.4
mg/l, LDH was very high, these results support the diagnosis of SoJIA in
a background of a kerion. Patient received: antibiotic, systemic
antifungal, Corticosteroids, Hydroxychloroquine, Calcium and Vitamin D
to which he achieved good results.Consent:Witten informed consent was obtained from patient’s parent to publish
this report in accordance with the journal’s patient consent policy.Keywords:
Systemic-onset juvenile idiopathic arthritis; Systemic juvenile
idiopathic arthritis; Tinea capitis; eosinophilia; case report.
1.Introduction and literature review
Juvenile idiopathic arthritis is a group of arthritis that occur before
16 years and last more than 6 weeks after exclusion of other aetiologies
which is classified according to the International league of
Associations for Rheumatology (ILAR) into 3 subtypes according to the
clinical manifestations, complications and therapeutic options.(1–3)
Systemic-onset juvenile idiopathic arthritis (SoJIA) is a very special
subtype of juvenile idiopathic arthritis (JIA) that is characterized by
fever which has a characteristic one or two spikes (>39°C)
per day.(4) Also more than 80% of patients of this disease has a
transient salmon-coloured macular or maculopapular rash that that
accompanies the fever. They may have also myalgias and tenosynovitis and
arthritis which may be oligoarticular to polyarticular.(3) The widely
affected joints include wrists, knee, and ankles; but any joint can be
affected, even the temporomandibular joints(5), cervical spine(6),
hips(7), and the small joints of the hand and feet. SoJIA may present as
painless lymphadenopathy (25%) hepatomegaly, splenomegaly or
pericarditis which may be complicated by cardiac tamponade (3,4)
There is no specific laboratory features that distinguishes SoJIA from
other conditions, but the pattern of laboratory abnormalities may
support the diagnosis, for examples; microcytic hypochromic anaemia,
neutrophilic leucocytosis, thrombocytosis, high ESR, high CRP, high
serum ferritin, low serum albumin, mildly elevated AST, high D-dimer and
negative autoantibodies.(3)
The treatment of JIA as whole focuses on suppressing inflammation,
preserving functions, and preventing deformity and blindness.(8) the
currently available drugs include nonsteroidal anti-inflammatory drugs
(NSAID), Systemic corticosteroids and Disease-modifying anti-rheumatic
drugs (DMARDs).(3,9,10)
Eosinophil cells were associated with allergic bronchopulmonary
aspergillosis and asthma exacerbation due to fungal antigens.(11)
Moreover, a case report of kerion associated eosinophilia was described
in which a dermatophytid reaction was thought to be the cause which
responded to corticosteroid and antifungal.(12)
2 Case reports of 2 patients with systemic lupus erythromatosis in which
tinea capitis was disseminated, one of them was using steroid the other
was not.(13,14) and this is the first report related to juvenile
idiopathic arthritis.
Case report
History : In March 2021; a 5-years old Sudanese male from Algazira, center of
Sudan presented with bilateral ankle swelling, bilateral knee and hip
pain and fever which started 1 month prior to presentation. His mother
was also concerned about scales and hair loss all over the scalp which
started 2 months prior to presentation. His symptoms started insidiously
with the fever mainly at night and relieved by antipyretics. He had
anorexia and weight loss but neither abdominal pain, vomiting, diarrhea,
cough, upper respiratory tract symptoms, headache nor history of trauma.
He had a past history of right knee swelling which was resolved
spontaneously. He had no family history of autoimmune disease or
malignancy and not exposed to any medications.
Examination: On examination the patient was ill but not pale, jaundiced or cyanosed.
His weight was 15 Kg (along the 5th centile) (fig. 1).
The scalp had white-yellow scales with some swelling, hair loss and
dried pus over some areas of the scalp (Fig. 2). There were Bilateral
cervical lymphadenopathy which were non-tender, discrete and maximum
diameter was 1×1 cm.
Both ankle joints were Swollen (fig. 3),and tender to palpation and
there was restriction of movements. Other joint examinations were
normal.
Abdominal examination revealed palpable liver which was 4 cm below the
costal margin and palpable paraaortic lymph nodes.
Investigations: Complete blood count and peripheral blood picture revealed leucocytosis
(WBCS=13.4*\(10^{3}\) which is high), neutrophil% = 49%, lymphocyte%
= 38%, monocyte% = 5% and eosinophil% = 8% (mild eosinophilia)
Thrombocytosis (614*\(10^{3}\)) and mild hypochromia (Hb=10.3 g/dl,
MCV=71.8 fl, MCH=22.3 pg, MCHC=31.1 g/dl) were also present.
Anti-dsDNA antibody was 45 IU/ml (positive).
ANA profile was 0.8 Ratio (Equivocal).
CRP was 34.4 mg/l (high) and ESR = 49 mm/hr.
LDH was very high.
Patient was treated with:
Methylprednisolone 30mg/kg/day for 3 days.
Followed by oral prednisone 1mg/kg/day.
Hydroxychloroquine tabs 5mg/kg/day.
Griseofulvin syrup 7.3mg/kg/day.
Antibiotic
Calcium and vitamin D.
After 1 month of treatment follow-up the patient was improved and we
refer him to the ophthalmologist for slit lamp examination.
Discussion: In this case the full detailed history and proper clinical examination
in addition to laboratory findings are in favour of the diagnosis of
systemic-onset juvenile idiopathic arthritis. This case may show that,
musculoskeletal manifestations may be present earlier than any other
symptoms. Also, we noticed that in the lipid profile the HDL was very
high but serum ferritin and ESR was normal, a complicating macrophage
activation syndrome was putted in mind and then excluded.(15,16)
Does tinea capitis occur more extensively in this patient due to the
disease itself we don’t know fully but in a previous case report to a
patient with systemic lupus erythromatosis in which disseminated
infection occurred simultaneously at the time of the diagnosis before
even the use of corticosteroid.(13) in that case the causative agent was
Microsporum gypseum but unfortunately in our case the diagnosis was made
clinically only and microbiological consultation was not ordered due to
financial problems but what make our case unique is its association with
systemic-onset juvenile idiopathic arthritis and not Systemic lupus
erythromatosis even before the start of immunosuppressive
therapy.(13,14)
Mild peripheral eosinophilia explanation in our case was challenging;
whether it is related to a dermatophytid reaction with no obvious
morbilliform or lichenoid lesions or due to other causes that are not
typical with the present history such as drug tubulointerstitial
nephritis or any other occult helminthic infection. But according to the
other laboratory and history points the later causes were excluded and
we left with the occult dermatophytid reaction which was consistent with
the same observation from another case report of kerion due to T.
tonsurans with 21% eosinophil in the complete which was reduced to 6%
one month later after oral griseofulvin and corticosteroid were
used.(12) but unlike that case in which the patient was 45 year old
female with a clear medical background unlike our case. But this may
point to the fact that complete blood count is not routinely ordered in
tinea capitis and eosinophilia may be underreported if we associate this
to the fact that eosinophil recognizes ß-glucan of the fungal cell wall
and react to it by releasing its granules and this area is an area of
investigation in the future.(11)
Conclusion: Physicians should be alert to the presentation of systemic-onset JIA in
our country in order to make prompt diagnosis and treatment decisions as
early as possible. Careful follow-up of prolonged febrile patients with
arthritis of unknown origin is important to reaching the diagnosis early
and initiating treatment.
Conflict of interest:NO conflict of interest.
Recommendations:
- Further studies about the eosinophil count and its role in tinea
capitis and systemic-onset juvenile idiopathic arthritis.
- Further studies about the immune response against fungi in the setting
of juvenile idiopathic arthritis.
- Multidisciplinary team consultation (rheumatologist, ophthalmologist,
orthopaedics and paediatrician) in case of SoJIA.
- Educate the patients about the disease and its complications, which
are important to monitor the disease and long-term morbidity and
mortality.
References:
1. Ravelli A MA. Juvenile idiopathic arthritis. Lancet.
2007;369:767–78.
2. Petty RE, Southwood TR MP. International League of Associations for
Rheumatology classification of juvenile idiopathic arthritis second
revision, Edmonton, 2001. J Rheumatol. 2004;31((2)):390–2.
3. Lee, Jennifer JY and RS. “Systemic juvenile idiopathic arthritis.”
Pediatr Clin. 2018;(65.4):691–709.
4. Calabro JJ, Holgerson WB SG. Juvenile rheumatoid arthritis: a general
review and report of 100 patients observed for 15 years. Semin Arthritis
Rheum. 1976;5(3):257–98.
5. Ringold S CR. The temporomandibular joint in juvenile idiopathic
arthritis: frequently used and frequently arthritic. Pediatr Rheumatol
Online J. 2009;7(1):11.
6. Ornilla E, Ansell BM SA. Cervical spine involvement in patients with
chronic arthritis undergoing orthopaedic surgery. Ann Rheum Dis.
1972;31:364–8.
7. Modesto C, Woo P, García-Consuegra J, Merino R, García-Granero M,
Arnal C, et al. Systemic onset juvenile chronic arthritis, polyarticular
pattern and hip involvement as markers for a bad prognosis. Clin Exp
Rheumatol. 2001;19(2):211–7.
8. Nelson essentials of pediatrics, 7th edition.
9. Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, et al. The
outcomes of juvenile idiopathic arthritis in children managed with
contemporary treatments: results from the ReACCh-Out cohort. Ann Rheum
Dis. 2015 Oct;74(10):1854–60.
10. Horneff G, Schulz AC, Klotsche J, Hospach A, Minden K, Foeldvari I,
et al. Experience with etanercept, tocilizumab and interleukin-1
inhibitors in systemic onset juvenile idiopathic arthritis patients from
the BIKER registry. Arthritis Res Ther. 2017 Nov;19(1):256.
11. Manuscript A. NIH Public Access. 2009;181(4):2907–15.
12. Martin ES, Elewski BE. bacterial pyoderma. 2003;177–9.
13. Sanusi T, Gong J, Wang X, Zhao M, Zhao Y, An X, et al. Disseminated
Favus Caused by Microsporum gypseum in a Patient with Systemic Lupus
Erythematosus. 2016;(c):270–1.
14. Feng J, Liu F, Wu F, Deng Q De. Tinea Infection with Scutula-like
Lesions Caused by Microsporum Gypseum in a SLE Patient : Case Report
and Literature Review. 2013;255–8.
15. Cortis E, Insalaco A. Macrophage activation syndrome in juvenile
idiopathic arthritis. Acta Paediatr Suppl. 2006 Jul;95(452):38–41.
16. Ravelli, A., Magni-Manzoni, S., Pistorio, A. et al. Preliminary
diagnostic guidelines for macrophage acti- vation syndrome complicating
systemic juvenile idiopathic arthritis. J Pediatr.
2004;12.016(146):598–604.
17. Colella, M. , Buttaro, G. , Masi, L. , Palma, E. , Amelio, R. and
Vallone A. The difficult management of systemic-onset juvenile
rheumatoid arthritis. Level of serum ferritin as aspecific diagnostic
finding. Open J Pediatr. 2012;2:53–5.
18. Jandus, P., Wang, W., Seitz, M. et al. High serum ferritin in
adult-onset still’s disease. International Journal of Clinical Medicine.
2010;1:81–3.
19. Meijvis, H., Endeman, A.B.M., Geers, E.J. and Borg EJ. Extremely
high serum ferritin levels as diagnostic tool in adult-onset still’s
disease. Netherl J Med. 2007;65:212–4.